Skip to content

Medical-device intelligence

DFC: Lipoprotein, Low-Density, Antigen, Antiserum, Control

FDA product code DFC: Lipoprotein, Low-Density, Antigen, Antiserum, Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DFC
FDA device name
Lipoprotein, Low-Density, Antigen, Antiserum, Control
Device class
2
Regulation number
866.5600
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

43 clearance records and 6 recall records in the covered releases, across 31 source company names and 1 product codes. Dated history runs from Oct 18, 1977 to Jun 16, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202610
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DFC · Lipoprotein, Low-Density, Antigen, Antiserum, Control436

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

49 matching records
Device / recordCompany in FDA recordSourceSource date
Lipoprotein (a) Molarity AssayK253069 · DFCDiazyme Laboratories, Inc.510(k)Jun 16, 2026FDA decision date
Tina-quant Lipoprotein(a) Gen.2 MolarityK241220 · DFCRoche Diagnostics Operations510(k)Jan 24, 2025FDA decision date
Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403Z-1017-2025 · DFCRandox Laboratories, LimitedRecallJan 23, 2025FDA classification date
Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757Z-1018-2025 · DFCRandox Laboratories, LimitedRecallJan 23, 2025FDA classification date
Lp(a) UltraK211058 · DFCSENTINEL CH. SpA510(k)Dec 22, 2022FDA decision date
Apolipoprotein B is an in vitro diagnostic assay for the quantitative determination of apolipoprotein B in human serum or plasma. Antibodies to a…Z-1994-2019 · DFCAbbott Laboratories, IncRecallJul 19, 2019FDA record creation date
Diazyme Lipoprotein (a) AssayK180074 · DFCDiazyme Laboratories, Inc.510(k)Mar 22, 2018FDA decision date
ADVIA CHEMISTRY LIPOPROTEIN(A) REAGENT ADVIA CHEMISTRY LIPOPROTEIN(A) CALIBRATORK123046 · DFCSiemens Healthcare Diagnostics, Inc.510(k)Dec 20, 2012FDA decision date
COBAS C TINA-QUANT LIPOPROTEIN (A) GEN 2 ASSAY MODEL 05852625190; PRECISET LP (A) GEN 2 CALIFRATOR SET MODEL 05852641160K122722 · DFCRoche Diagnostics510(k)Nov 29, 2012FDA decision date
Wako Autokit Lp(a) Calibrator, model code# 998-41491, packaged in 1 ml bottles, 2 bottles/kit, and labeled in part ***Manufactured by: Wako Pure …Z-1377-2012 · DFCWako Chemicals USA, Inc.RecallApr 6, 2012FDA classification date
DIAZYME LP(A) ASSAYK082488 · DFCGeneral Atomics510(k)Jan 13, 2009FDA decision date
LIPOPROTEIN(A), LIPOPROTEIN(A) CALIBRATOR, LIPOPROTEIN (A) CONTROL, CONTROL HIGHK063838 · DFCThermo Electron OY510(k)Sep 27, 2007FDA decision date
QUANTIA LA(A)K050487 · DFCBiokit, S.A.510(k)Apr 26, 2005FDA decision date
Lp(a) Diluent packaged into 60 mL bottles, Catalog #23817, Lot #s 238017-01 & 238017-03; 480 mL bulk catalog # 95046B, Lot # 238017-02. 60 mL b…Z-0636-05 · DFCDiasorin Inc.RecallMar 18, 2005FDA classification date
K-Assay Lp(a) ControlZ-0940-04 · DFCKamiya Biomedical CompanyRecallJul 20, 2004FDA classification date
K-ASSAY LP(A) CONTROLSK023853 · DFCKamiya Biomedical Co.510(k)Dec 13, 2002FDA decision date
K-ASSAY LP(A) ASSAYK021660 · DFCKamiya Biomedical Co.510(k)Jul 25, 2002FDA decision date
LP(A)-LATEX SEIKEN ASSAY KITK013359 · DFCDenka Seiken'S510(k)Mar 8, 2002FDA decision date
N LATEX LP(A)K013128 · DFCDade Behring, Inc.510(k)Jan 18, 2002FDA decision date
TINA-QUANT APOLIPOPROTEIN B VER.2K013206 · DFCRoche Diagnostics Corp.510(k)Nov 16, 2001FDA decision date
TINA-QUANT APOLIPOPROTEIN B VER.2K013207 · DFCRoche Diagnostics Corp.510(k)Nov 13, 2001FDA decision date
WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARAK001929 · DFCWako Chemicals USA, Inc.510(k)Jul 24, 2000FDA decision date
WAKO AUTOKIT LP(A) & LP(A) CALIBRATOR/AEROSETK001931 · DFCWako Chemicals USA, Inc.510(k)Jul 24, 2000FDA decision date
WAKO AUTOKIT LP(A) & LP(A) CALIBRATOR/COBAS BIOK001933 · DFCWako Chemicals USA, Inc.510(k)Jul 24, 2000FDA decision date
WAKO AUTOKIT LP(A) & LP(A) CALIBRATOR/BECKMAN CXK001934 · DFCWako Chemicals USA, Inc.510(k)Jul 24, 2000FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗